What does DAMMEKENS FARMA do?

DAMMEKENS FARMA is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 2 September 2016, 1 establishment.

What is the address of DAMMEKENS FARMA?

The registered office of DAMMEKENS FARMA is located at Rijckerstraat 13, 3770 Riemst.

Is DAMMEKENS FARMA still active?

Yes. According to the CBE (17 September 2026) DAMMEKENS FARMA is active, legal situation “Normale toestand”, started on 2 September 2016.

Is DAMMEKENS FARMA registered on Peppol?

Yes, DAMMEKENS FARMA is registered on the Peppol network with ID 0208:0661942351.

What is the enterprise number of DAMMEKENS FARMA?

The enterprise number of DAMMEKENS FARMA is BE0661942351.

When was DAMMEKENS FARMA founded?

DAMMEKENS FARMA was founded on 2 September 2016.

Who are the directors of DAMMEKENS FARMA?

According to the 2025 annual accounts, the directors of DAMMEKENS FARMA are: Gudrun Dammekens.

Is DAMMEKENS FARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 September 2016; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DAMMEKENS FARMA make in 2025?

DAMMEKENS FARMA posted a profit after taxes of € 7,159 in financial year 2025.

What is the revenue of DAMMEKENS FARMA?

As a small company, DAMMEKENS FARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 30,976.

DAMMEKENS FARMA (Private Limited) - Riemst - BE0661942351

Dossier DAMMEKENS FARMA, printed on 17 September 2026 from databakkes.be/en/0661942351/dammekens-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 37 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DAMMEKENS FARMA from Riemst, company number BE0661942351, closed financial year 2025 with a result of € 7,159 after tax. For that financial year DAMMEKENS FARMA recorded a gross margin of € 30,976 and equity of € 888,553. Compared with financial year 2024, the result moved from € 7,419 to € 7,159. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 26, 2026.

What it is worth Growing

€ 888,553

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 7,159

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 6,720

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 876,153.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 444,359

▼ 10% vs 2024

€ 64,257 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 8,350

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,733

▼ 34% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 31,951 Gross margin 2022: € 31,951 First fiscal year in the series	€ 30,253 Gross margin 2023: € 30,253 ▼ 5% vs 2022 (€ 31,951) Unfavourable step	€ 31,703 Gross margin 2024: € 31,703 ▲ 5% vs 2023 (€ 30,253) Favourable step	€ 30,976 Gross margin 2025: € 30,976 ▼ 2% vs 2024 (€ 31,703) Unfavourable step	▼ 2%
Profit after taxes	€ 6,600 Profit after taxes 2022: € 6,600 First fiscal year in the series	€ 5,881 Profit after taxes 2023: € 5,881 ▼ 11% vs 2022 (€ 6,600) Unfavourable step	€ 7,419 Profit after taxes 2024: € 7,419 ▲ 26% vs 2023 (€ 5,881) Favourable step	€ 7,159 Profit after taxes 2025: € 7,159 ▼ 4% vs 2024 (€ 7,419) Unfavourable step	▼ 4%
Equity	€ 868,093 Equity 2022: € 868,093 First fiscal year in the series	€ 873,975 Equity 2023: € 873,975 ▲ 1% vs 2022 (€ 868,093) Favourable step	€ 881,394 Equity 2024: € 881,394 ▲ 1% vs 2023 (€ 873,975) Favourable step	€ 888,553 Equity 2025: € 888,553 ▲ 1% vs 2024 (€ 881,394) Favourable step	▲ 1%
Total debts	€ 603,310 Total debts 2022: € 603,310 First fiscal year in the series	€ 572,645 Total debts 2023: € 572,645 ▼ 5% vs 2022 (€ 603,310) Favourable step	€ 543,357 Total debts 2024: € 543,357 ▼ 5% vs 2023 (€ 572,645) Favourable step	€ 512,560 Total debts 2025: € 512,560 ▼ 6% vs 2024 (€ 543,357) Favourable step	▼ 6%
Cash	€ 6,432 Cash 2022: € 6,432 First fiscal year in the series	€ 6,342 Cash 2023: € 6,342 ▼ 1% vs 2022 (€ 6,432) Unfavourable step	€ 8,678 Cash 2024: € 8,678 ▲ 37% vs 2023 (€ 6,342) Favourable step	€ 6,720 Cash 2025: € 6,720 ▼ 23% vs 2024 (€ 8,678) Unfavourable step	▼ 23%
Land & buildings	€ 230,000 Land & buildings 2022: € 230,000 First fiscal year in the series	€ 218,000 Land & buildings 2023: € 218,000 ▼ 5% vs 2022 (€ 230,000) Unchanged	€ 206,000 Land & buildings 2024: € 206,000 ▼ 6% vs 2023 (€ 218,000) Unchanged	€ 194,000 Land & buildings 2025: € 194,000 ▼ 6% vs 2024 (€ 206,000) Unchanged	▼ 6%
Retained profit	€ 855,693 Retained profit 2022: € 855,693 First fiscal year in the series	€ 861,575 Retained profit 2023: € 861,575 ▲ 1% vs 2022 (€ 855,693) Favourable step	€ 868,994 Retained profit 2024: € 868,994 ▲ 1% vs 2023 (€ 861,575) Favourable step	€ 876,153 Retained profit 2025: € 876,153 ▲ 1% vs 2024 (€ 868,994) Favourable step	▲ 1%
Bank debt	€ 587,437 Bank debt 2022: € 587,437 First fiscal year in the series	€ 540,453 Bank debt 2023: € 540,453 ▼ 8% vs 2022 (€ 587,437) Favourable step	€ 492,764 Bank debt 2024: € 492,764 ▼ 9% vs 2023 (€ 540,453) Favourable step	€ 444,359 Bank debt 2025: € 444,359 ▼ 10% vs 2024 (€ 492,764) Favourable step	▼ 10%
Balance sheet total	€ 1,471,403 Balance sheet total 2022: € 1,471,403 First fiscal year in the series	€ 1,446,620 Balance sheet total 2023: € 1,446,620 ▼ 2% vs 2022 (€ 1,471,403) Unchanged	€ 1,424,751 Balance sheet total 2024: € 1,424,751 ▼ 2% vs 2023 (€ 1,446,620) Unchanged	€ 1,401,113 Balance sheet total 2025: € 1,401,113 ▼ 2% vs 2024 (€ 1,424,751) Unchanged	▼ 2%

Key figures of DAMMEKENS FARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DAMMEKENS FARMA?

What happened at DAMMEKENS FARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 26, 2026 New annual accounts for financial year 2025: profit of € 7,159 (▼ 4% vs 2024). Source: NBB ↗
Sep 2, 2016 New establishment in Riemst. KBO
Sep 2, 2016 Start of the company according to the CBE. KBO
2016 Gudrun Dammekens became a director. NBB

In short

From € 6,600 profit in 2022 to € 7,159 profit in 2025.

Paid € 7,406 in corporate taxes since 2022.

Best year ever: 2024, with € 7,419 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DAMMEKENS FARMA? We notify you, reason included.

Follow DAMMEKENS FARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gudrun Dammekens

DAMMEKENS FARMA

Apotheek Membruggen 98.7%

Behind DAMMEKENS FARMA is Gudrun Dammekens. It owns 98.7% of Apotheek Membruggen itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Gudrun Dammekens

Director

Also active at: APOTHEEK MEMBRUGGEN

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Rijckerstraat 13

3770 Riemst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

APOTHEEK MEMBRUGGEN same network

€ 4,286 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0661.942.351

VAT number

BE 0661.942.351

Registered office

Rijckerstraat 13, 3770 Riemst

Names & denominations

DAMMEKENS FARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 September 2016

Peppol

Active · Active since 26 Jul 2024

Activities · NACE

Activiteiten van holdings

Holdings

View on CBE Public ↗ Annual accounts (NBB) ↗

DAMMEKENS FARMA

Warning lights

Financials

What happened to DAMMEKENS FARMA?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions